NusaTrip (NASDAQ: NUTR) adds $2.25M via IPO over-allotment exercise

Rhea-AI Filing Summary

NusaTrip Incorporated reported that the underwriters in its recent initial public offering fully exercised their over-allotment option. On September 5, 2025, the company issued and sold 562,500 shares of common stock at $4.00 per share, generating additional gross proceeds of approximately $2,250,000.

Including this over-allotment exercise, NusaTrip has now raised aggregate gross proceeds of $17,250,000 in its IPO, before underwriting discounts, commissions and offering expenses. The additional capital strengthens the company’s cash position following its Nasdaq listing, while modestly increasing its total shares sold to public investors through the IPO process.

false 0002006468 0002006468 2025-09-05 2025-09-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 5, 2025

NusaTrip Incorporated

(Exact name of registrant as specified in its charter)

Nevada		001-42519		99-2217461
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

28F AIA Central, Jl. Jend. Sudirman No.Kav. 48A, RT.5/RW.4,Karet, Semanggi, Kota Jakarta Selatan, Daerah Khusus Ibukota, Jakarta, Indonesia		12930
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code +62 21 5060 8747

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		NUTR		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

As previously disclosed, on August 18, 2025, NusaTrip Incorporated, a Nevada corporation (the “Company”) (Nasdaq: NUTR), consummated its initial public offering (the “IPO”) of 3,750,000 shares of the Company’s common stock, $0.0001 par value per share (each, a “Common Stock” and the Common Stocks sold in the IPO are hereafter referred as the “IPO Shares”). The Company has also granted the underwriters a 45-day option to purchase up to an additional 562,500 Common Stocks to cover over-allotments (the “Over-Allotment Shares”), if any (the “Over-Allotment Option”).

On September 5, 2025, the Company issued and sold to the underwriter 562,500 Common Stocks at a price of $4.00 per share, pursuant to the full exercise of the Over-Allotment Option, resulting in additional gross proceeds of approximately $2,250,000. As a result, the Company has raised aggregate gross proceeds of $17,250,000 in the IPO, including the exercise of the Over-Allotment Option, prior to deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 5, 2025	NusaTrip Incorporated
	/s/ Tjin Patrick Soetanto
	Name:	Tjin Patrick Soetanto
	Title:	Chief Executive Officer

3

FAQ

What did NusaTrip (NUTR) announce in this 8-K filing?

NusaTrip disclosed that its IPO underwriters fully exercised their over-allotment option, leading to an additional sale of 562,500 common shares at $4.00 per share.

How much additional capital did NusaTrip (NUTR) raise from the over-allotment?

The full exercise of the over-allotment option resulted in additional gross proceeds of approximately $2,250,000 before underwriting discounts, commissions and expenses.

What are NusaTrip’s total IPO gross proceeds after the over-allotment?

After including the over-allotment exercise, NusaTrip reports aggregate IPO gross proceeds of $17,250,000, before offering costs and underwriting fees.

At what price were NusaTrip’s over-allotment shares sold?

The 562,500 over-allotment shares of NusaTrip common stock were sold to the underwriter at a price of $4.00 per share.

What type of securities did NusaTrip (NUTR) issue in this transaction?

NusaTrip issued additional shares of its common stock, par value $0.0001 per share, pursuant to the IPO over-allotment option granted to the underwriters.

Does this 8-K mean NusaTrip is making a new offer of securities?

No. The report states it does not constitute an offer to sell or a solicitation to buy securities where such actions would be unlawful without proper registration or qualification.